Telmisartan Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064848
  • May 2021
  • Pharmaceuticals
  • 144 Pages
Download Sample
The Telmisartan market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Telmisartan market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Mylan N.V., Hikma Pharmaceuticals PLC, Exelan Pharmaceuticals, Inc., Macleods Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Torrent Pharmaceuticals Ltd., Jubilant Cadista., Aurobindo Pharma., Solco Healthcare, Sandoz International GmbH
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Telmisartan market along with their effects over the forecast period. Similarly, according to the region Telmisartan market research report includes the study of opportunities available in the market situation.

The Telmisartan market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Telmisartan Market:
The Telmisartan market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Mylan N.V., Hikma Pharmaceuticals PLC, Exelan Pharmaceuticals, Inc., Macleods Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Torrent Pharmaceuticals Ltd., Jubilant Cadista., Aurobindo Pharma., Solco Healthcare, Sandoz International GmbH

Telmisartan Market Segmentation Analysis:
Indication
Hypertension
Cardiac Arrest
Stroke
Composition
Single
Combinational
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Telmisartan Market Segmentation by Regions:
In regional analysis, Telmisartan market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Telmisartan market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Telmisartan Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Telmisartan Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Telmisartan Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Telmisartan Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Telmisartan Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Telmisartan market, according to the key region.
  • To study the Telmisartan market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Telmisartan market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Telmisartan research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Telmisartan market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Telmisartan market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Telmisartan market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Telmisartan market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Telmisartan market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Mylan N.V.
  • Hikma Pharmaceuticals PLC
  • Exelan Pharmaceuticals, Inc.
  • Macleods Pharmaceuticals Ltd.
  • Zydus Pharmaceuticals, Inc.
  • Torrent Pharmaceuticals Ltd.
  • Jubilant Cadista.
  • Aurobindo Pharma.
  • Solco Healthcare
  • Sandoz International GmbH
  • Hypertension
  • Cardiac Arrest
  • Stroke
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Telmisartan Market Snapshot
          2.1.1. Global Telmisartan Market By Indication,2019
               2.1.1.1.Hypertension
               2.1.1.2.Cardiac Arrest
               2.1.1.3.Stroke
          2.1.2. Global Telmisartan Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online Pharmacies
          2.1.3. Global Telmisartan Market By End-use,2019
          2.1.4. Global Telmisartan Market By Geography,2019

3. Global Telmisartan Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Telmisartan Market Size (US$), By Indication, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Indication, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Indication, 2020
     4.2. Global Telmisartan Market Size (US$), By Indication, 2018 – 2028

5. Global Telmisartan Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Telmisartan Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Telmisartan Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Telmisartan Market Size (US$), By End-use, 2018 – 2028

7. Global Telmisartan Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Telmisartan Market Analysis, 2018 – 2028 
          7.2.1. North America Telmisartan Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Telmisartan Market Size (US$), By Indication, 2018 – 2028
          7.2.3. North America Telmisartan Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Telmisartan Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Telmisartan Market Analysis, 2018 – 2028 
          7.3.1.  Europe Telmisartan Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Telmisartan Market Size (US$), By Indication, 2018 – 2028
          7.3.3. Europe Telmisartan Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Telmisartan Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Telmisartan Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Telmisartan Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Telmisartan Market Size (US$), By Indication, 2018 – 2028
          7.4.3. Asia Pacific Telmisartan Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Telmisartan Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Telmisartan Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Telmisartan Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Telmisartan Market Size (US$), By Indication, 2018 – 2028
          7.5.3. Latin America Telmisartan Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Telmisartan Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Telmisartan Market Analysis, 2018 – 2028 
          7.6.1.  MEA Telmisartan Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Telmisartan Market Size (US$), By Indication, 2018 – 2028
          7.6.3. MEA Telmisartan Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Telmisartan Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Telmisartan Providers
        8.4.1 Mylan N.V.
                8.4.1.1 Business Description
                8.4.1.2 Mylan N.V. Geographic Operations
                8.4.1.3 Mylan N.V. Financial Information
                8.4.1.4 Mylan N.V. Product Positions/Portfolio
                8.4.1.5 Mylan N.V. Key Developments
        8.4.2 Hikma Pharmaceuticals PLC
                8.4.2.1 Business Description
                8.4.2.2 Hikma Pharmaceuticals PLC Geographic Operations
                8.4.2.3 Hikma Pharmaceuticals PLC Financial Information
                8.4.2.4 Hikma Pharmaceuticals PLC Product Positions/Portfolio
                8.4.2.5 Hikma Pharmaceuticals PLC Key Developments
        8.4.3 Exelan Pharmaceuticals, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Exelan Pharmaceuticals, Inc. Geographic Operations
                8.4.3.3 Exelan Pharmaceuticals, Inc. Financial Information
                8.4.3.4 Exelan Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.3.5 Exelan Pharmaceuticals, Inc. Key Developments
        8.4.4 Macleods Pharmaceuticals Ltd.
                8.4.4.1 Business Description
                8.4.4.2 Macleods Pharmaceuticals Ltd. Geographic Operations
                8.4.4.3 Macleods Pharmaceuticals Ltd. Financial Information
                8.4.4.4 Macleods Pharmaceuticals Ltd. Product Positions/Portfolio
                8.4.4.5 Macleods Pharmaceuticals Ltd. Key Developments
        8.4.5 Zydus Pharmaceuticals, Inc.
                8.4.5.1 Business Description
                8.4.5.2 Zydus Pharmaceuticals, Inc. Geographic Operations
                8.4.5.3 Zydus Pharmaceuticals, Inc. Financial Information
                8.4.5.4 Zydus Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.5.5 Zydus Pharmaceuticals, Inc. Key Developments
        8.4.6 Torrent Pharmaceuticals Ltd.
                8.4.6.1 Business Description
                8.4.6.2 Torrent Pharmaceuticals Ltd. Geographic Operations
                8.4.6.3 Torrent Pharmaceuticals Ltd. Financial Information
                8.4.6.4 Torrent Pharmaceuticals Ltd. Product Positions/Portfolio
                8.4.6.5 Torrent Pharmaceuticals Ltd. Key Developments
        8.4.7 Jubilant Cadista.
                8.4.7.1 Business Description
                8.4.7.2 Jubilant Cadista. Geographic Operations
                8.4.7.3 Jubilant Cadista. Financial Information
                8.4.7.4 Jubilant Cadista. Product Positions/Portfolio
                8.4.7.5 Jubilant Cadista. Key Developments
        8.4.8 Aurobindo Pharma.
                8.4.8.1 Business Description
                8.4.8.2 Aurobindo Pharma. Geographic Operations
                8.4.8.3 Aurobindo Pharma. Financial Information
                8.4.8.4 Aurobindo Pharma. Product Positions/Portfolio
                8.4.8.5 Aurobindo Pharma. Key Developments
        8.4.9 Solco Healthcare
                8.4.9.1 Business Description
                8.4.9.2 Solco Healthcare Geographic Operations
                8.4.9.3 Solco Healthcare Financial Information
                8.4.9.4 Solco Healthcare Product Positions/Portfolio
                8.4.9.5 Solco Healthcare Key Developments
        8.4.10 Sandoz International GmbH
                8.4.10.1 Business Description
                8.4.10.2 Sandoz International GmbH Geographic Operations
                8.4.10.3 Sandoz International GmbH Financial Information
                8.4.10.4 Sandoz International GmbH Product Positions/Portfolio
                8.4.10.5 Sandoz International GmbH Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Telmisartan Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Telmisartan Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Telmisartan Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Telmisartan Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Telmisartan Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Telmisartan Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Telmisartan Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Telmisartan Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Telmisartan Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Telmisartan Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Telmisartan Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Telmisartan Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Telmisartan Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Telmisartan Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Telmisartan Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Telmisartan Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Telmisartan: Market Segmentation 
FIG. 2 Global Telmisartan Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Telmisartan Market, By Indication, 2019 (US$ Mn) 
FIG. 5 Global Telmisartan Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Telmisartan Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Telmisartan Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Telmisartan Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Telmisartan Providers, 2019
FIG. 11 Global Telmisartan Market Revenue Contribution, By Indication, 2019 & 2028 (Value %) 
FIG. 12 Global Telmisartan Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Telmisartan Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Telmisartan Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Telmisartan Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Telmisartan Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Telmisartan Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Telmisartan Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Telmisartan market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Telmisartan Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Telmisartan Market Value, By Segment1, 2018 – 2028
TABLE  North America Telmisartan Market Value, By Segment2, 2018 – 2028
TABLE  North America Telmisartan Market Value, By Country, 2018 – 2028
TABLE  Europe Telmisartan Market Value, By Segment1, 2018 – 2028
TABLE  Europe Telmisartan Market Value, By Segment2, 2018 – 2028
TABLE  Europe Telmisartan Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Telmisartan Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Telmisartan Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Telmisartan Market Value, By Country, 2018 – 2028
TABLE  Latin America Telmisartan Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Telmisartan Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Telmisartan Market Value, By Country, 2018 – 2028
TABLE  MEA Telmisartan Market Value, By Segment1, 2018 – 2028
TABLE  MEA Telmisartan Market Value, By Segment2, 2018 – 2028
TABLE  MEA Telmisartan Market Value, By Country, 2018 – 2028
TABLE  Mylan N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hikma Pharmaceuticals PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Exelan Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Macleods Pharmaceuticals Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zydus Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Torrent Pharmaceuticals Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Jubilant Cadista.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aurobindo Pharma.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Solco Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sandoz International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Telmisartan Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Telmisartan Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Telmisartan Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Telmisartan Market, By Geography, 2019 (US$ Mn)
FIG.  Global Telmisartan Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Telmisartan Providers, 2016
FIG.  Global Telmisartan Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Cardiac Arrest Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Stroke Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Telmisartan Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Telmisartan Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Telmisartan Market Value, 2018 – 2028, (US$ Mn)